Search
Collplant Biotechnologies Ltd
CLGNAdd to Watchlist
0.299USD
-0.001-0.30%
Close 07-31 16:00（ET）Quotes delayed by 15 min
3.82MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31No earnings forecast score is currently available for Collplant Biotechnologies Ltd. The Biotechnology & Medical Research industry's average is 8.14. The average price target is 11.50, with a high of 12.00 and a low of 11.00.
Analyst Rating
Based on
0
analysts
--
Current Rating
11.000
Target Price
+3425.64%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Collplant Biotechnologies Ltd
CLGN
0
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Collplant Biotechnologies Ltd's expected revenue for the next quarter?
Collplant Biotechnologies Ltd's expected revenue is 9.80M.
What is Collplant Biotechnologies Ltd's price target?
Analysts forecast that Collplant Biotechnologies Ltd's price target is USD 11.50, with the highest forecast at USD 12.00 and the lowest forecast at USD 11.00.
How have Collplant Biotechnologies LtdCLGN's recent earnings per share performed?
The market expectation was USD -0.23, while Collplant Biotechnologies LtdCLGN's earnings per share (EPS) for the previous quarter was USD -0.25. EPS for the next quarter is expected at USD 0.35.